Skip to main content
Log in

Comparison of Antihypertensive Efficacy of Carvedilol, a New Vasodilating β-Blocker, versus Atenolol

A Double-Blind Study

  • Short Communication
  • Poster Presentation
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Bartsch W, Sponer G, Strein K, Müller-Beckmann B, von Mollendorff E, et al. Pharmakologie und klinische Pharmakologie des neuen vasodilatierenden Beta-Rezeptoren-Blockers BM 14190. Therapiewoche 32: 46, 1982

    Google Scholar 

  • Eggertsen R, Andrén L, Sivertsson R, Hansson L. Acute hemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients. European Journal of Clinical Pharmacology 27: 19–22, 1984a

    PubMed  CAS  Google Scholar 

  • Eggertsen R, Sivertsson R, Andren L, Hansson L. Hemodynamic effects of carvedilol, a new beta adrenoceptor blocker and precapillary vasodilator in essential hypertension. A double-blind comparison with propranolol. Journal of Hypertension 2: 529–534, 1984b

    Article  PubMed  CAS  Google Scholar 

  • Kirk RE. Experimental design: procedures for the behavioral sciences, pp. 489–564, Brooks/Cole Publishing Company, 1982

  • Meyer-Sabellek WA, Schulte KL, Thiede HM, Gotzen R. Acute hypotensive response of a new antihypertensive drug (BM 14190) in essential hypertensive patients. Journal of Hypertension 1 (Suppl. 2): 351–352, 1983

    Google Scholar 

  • Simon G, Kiowski W, Julian S. Effect of systemic autonomic inhibition of the haemodynamic response to antihypertensive therapy with timolol. International Journal of Clinical Pharmacology and Biopharmacy 12: 507–510, 1979

    Google Scholar 

  • Simon G, Franciosa JA, Gimenez HJ, Cohn JN. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients. Hypertension 3: 262–268, 1981

    Article  PubMed  CAS  Google Scholar 

  • Sponer G, Müller-Beckmann B. Studies on the mechanism of the vasodilating activity of BM 14190. Naunyn-Schmiedeberg’s Archives of Pharmacology R 183: 322, 1983

    Google Scholar 

  • Tomlinson B, Cronin CJ, Graham BR, Smith CCT, Prichard BNC. Haemodynamics and pharmacokinetics of carvedilol (BM 14190). British Journal of Clinical Pharmacology 19: 566P-567P, 1985

    Google Scholar 

  • Tomlinson B, Cronin CJ, Graham BR, Prichard BNC. Acute haemodynamics of carvedilol compared to propranolol, labetalol and pindolol. British Journal of Clinical Pharmacology 21: 581P-582P, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Cesaris, R., Ranieri, G., Chiarappa, R. et al. Comparison of Antihypertensive Efficacy of Carvedilol, a New Vasodilating β-Blocker, versus Atenolol. Drugs 36 (Suppl 6), 102–105 (1988). https://doi.org/10.2165/00003495-198800366-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800366-00017

Keywords

Navigation